Essential thrombocythemia, also known as primary thrombocythemia, is a rare blood disease characterized by an overproduction of platelets in the bone marrow. The excessive number of platelets increases the risk of thrombus formation, which can lead to severe health issues such as stroke, heart attack, or pulmonary embolism. Platelets play a crucial role in clotting blood to prevent excessive bleeding. Essential thrombocythemia is considered an acquired genetic condition, meaning it occurs when specific genes undergo mutations or changes.
The condition is often detected during a routine blood test, which reveals abnormally high platelet levels. In some cases, individuals may not initially experience any symptoms, and immediate treatment may not be necessary. Although essential thrombocythemia is not curable, appropriate treatment strategies can help reduce the risk of developing serious complications.
The main objective of treating essential thrombocythemia is to minimize the likelihood of thrombotic events. The approach to treatment varies based on individual factors, and for those without symptoms, a strategy known as watchful waiting may be recommended. Medications aimed at preventing blood clots and reducing platelet levels are commonly prescribed by healthcare providers to manage essential thrombocythemia.
Symptoms of essential thrombocythemia can vary among individuals as it progresses gradually, leading to increased production of platelets in the bone marrow and elevated platelet levels. It is possible to have this condition without experiencing any symptoms. However, as platelet levels rise, you may start to exhibit symptoms associated with blood clotting. While blood clots can develop anywhere in the body, they tend to occur more frequently in the brain, hands, or feet in cases of essential thrombocythemia.
Essential thrombocythemia manifests through signs and symptoms that arise as a result of elevated platelet counts, leading to the formation of blood clots (thrombi). These symptoms may include:
When a blood clot forms in the arteries that carry blood to the brain, it can lead to a temporary interruption of blood flow to a specific area of the brain. This interruption can result in a stroke or a transient ischemic attack (TIA), which are characterized by the following signs and symptoms:
In some cases, individuals with essential thrombocythemia (ET) and an exceptionally elevated platelet count may experience bleeding as a result of the condition. The signs and symptoms associated with bleeding in such cases can include:
In addition to the previously mentioned signs and symptoms, essential thrombocythemia (ET) may also present with the following manifestations:
Essential thrombocythemia is a genetic disorder that is acquired rather than being present at birth. It occurs when certain genes within cells undergo mutations or changes. Specifically, the mutations affect the genes JAK2, CALR, and MPL, which are responsible for regulating the production of blood cells in the bone marrow.
In summary, the mutations in these genes lead to an abnormal increase in platelet production, exceeding the body’s needs, and resulting in essential thrombocythemia.
The following factors increase the risk in developing essential thrombocythemia.
+66 2066 8888